I encourage all shareholders to read the pr's from approximately 2011 on. It will provide insight into Leo's expressions of high hopes that to date, have resulted in a .11 pps. Reading these press releases-which clearly generated enough excitement to get the pps up to near $5 per share -reminded me of the Boy Who Cried Wolf, which may explain why none of the recent releases move the stock price significantly upward. Tantalizing shareholders and potential investors with hints of greatness, none of which have yet to materialize, seem to be a theme. For example, In April 2011, Leo proclaims that the magnitude of K is great noting that he expects it to generate milestone payments that exceed $400 million plus sales royalties. In June 2011, Leo states that the company is evaluating every possible scenario that will maximize shareholder value [this theme has bee repeated over the years]. He then goes on to state that word of K is spreading throughout the industry as evidenced by the company being contacted by many of the world's foremost pharmaceutical companies. He proclaims being as optimistic as ever about K. In August, 2011, Leo proclaims that the light at the end of the tunnel for K is bright. 8 years later, K is in a coma. Similar expressions lace the press releases though the present, making me wonder if these latest expressions are just empty words.
News 
Market Data 
Discover 
